Also trades as: 0H8I.L (LSE) · $vol 0M
ARAY NASDAQ
Accuray Incorporated
1W: +30.6%
1M: +8.1%
3M: +3.7%
YTD: -66.9%
1Y: -83.0%
3Y: -89.7%
5Y: -92.8%
$0.28
+0.01 (+5.16%)
Weekly Expected Move ±21.7%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-05-12
Earliest Filing
2025-10-20
Latest Filing
partner: 4
Counterparties (Filed by ARAY)
4 relationshipsCompanies named in ARAY's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Dedication Capital, LLC | — | partner | Consulting agreement entered into for transformation board sponsorship services. | 2025-10-20 | View |
| C-RAD | — | partner | Partnered with Accuray to introduce the VitalHold breast cancer treatment package for the Radixact System. | 2022-11-02 | View |
| GE Healthcare | GEHC | partner | Global commercial partner to expand access and advance Precision Radiation Therapy. | 2022-11-02 | View |
| TomoTherapy Incorporated | — | partner | Wholly-owned subsidiary of Accuray Incorporated whose assets secure the credit agreement | 2021-05-12 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-19 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-29 | Material Agreement; Unregistered Equity Sales; Officer/Director Change; Other Events; Exhibits | Agreement | View |
| 2026-06-04 | Termination of Agreement; Regulation FD | View | |
| 2026-05-06 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-28 | Officer/Director Change; Exhibits | View | |
| 2026-04-07 | Material Agreement; Exhibits | Agreement | View |
| 2026-04-06 | Regulation FD; Exhibits | View | |
| 2026-02-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-09 | Non-Reliance on Previously Issued Financial Statements | View | |
| 2026-02-06 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2026-02-04 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-20 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-12-31 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-12-16 | Entry into Material Definitive Agreement; Costs Associated with Exit or Disposal Activities; Unregis | Agreement | View |
| 2025-11-19 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-20 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Departure/E | Agreement | View |
| 2025-09-19 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-22 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR